These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

596 related articles for article (PubMed ID: 16268420)

  • 21. Childhood autoimmune liver disease: indications and outcome of liver transplantation.
    Chai PF; Lee WS; Brown RM; McPartland JL; Foster K; McKiernan PJ; Kelly DA
    J Pediatr Gastroenterol Nutr; 2010 Mar; 50(3):295-302. PubMed ID: 20118802
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Liver disease recurrence after liver transplantation].
    Rakela B J
    Rev Med Chil; 2010 Apr; 138(4):504-10. PubMed ID: 20668801
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Recurrence of primary biliary cirrhosis, autoimmune cholangitis and primary sclerosing cholangitis after liver transplantation.
    Batts KP; Wang X
    Clin Liver Dis; 1998 May; 2(2):421-35, xi. PubMed ID: 15560041
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Concurrent de novo autoimmune hepatitis and recurrence of primary biliary cirrhosis post-liver transplantation.
    Tan CK; Sian Ho JM
    Liver Transpl; 2001 May; 7(5):461-5. PubMed ID: 11349269
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Liver transplantation and autoimmune liver diseases.
    Liberal R; Zen Y; Mieli-Vergani G; Vergani D
    Liver Transpl; 2013 Oct; 19(10):1065-77. PubMed ID: 23873751
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Potential benefit of mixed lymphocyte reaction assay-based immune monitoring after living donor liver transplantation for recipients with autoimmune hepatitis.
    Sakai H; Ishiyama K; Tanaka Y; Ide K; Ohira M; Tahara H; Abe T; Hirata F; Morimoto H; Hashimoto S; Tanimine N; Saeki Y; Shimizu S; Yano T; Kobayashi T; Tashiro H; Ohdan H
    Transplant Proc; 2014 Apr; 46(3):785-9. PubMed ID: 24767349
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Frequent overlap of active hepatitis in recurrent primary sclerosing cholangitis after living-donor liver transplantation relates to its rapidly progressive course.
    Miyagawa-Hayashino A; Egawa H; Yoshizawa A; Ueda Y; Ichida T; Ueno Y; Uemoto S; Harada K; Nakanuma Y
    Hum Pathol; 2011 Sep; 42(9):1329-36. PubMed ID: 21334714
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Trends in liver transplantation for autoimmune liver diseases: a Canadian study.
    Murillo Perez CF; Ivanics T; Claasen MPAW; Yoon P; Wallace D; Selzner N; Hirschfield GM; Hansen BE; Sapisochin G
    Can J Surg; 2022; 65(5):E665-E674. PubMed ID: 36223935
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The differences in post-liver transplant outcomes of patients with autoimmune hepatitis who present with overlapping autoimmune liver diseases.
    Lee DU; Ponder R; Lee K; Menegas S; Fan GH; Chou H; Jung D; Lee K; Hastie DJ; Urrunaga NH
    Hepatol Int; 2023 Jun; 17(3):720-734. PubMed ID: 36575337
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cholestatic Liver Diseases After Liver Transplant.
    Pena Polanco NA; Levy C; Martin EF
    Clin Liver Dis; 2017 May; 21(2):403-420. PubMed ID: 28364821
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Therapy of autoimmune hepatitis, primary biliary cirrhosis and primary sclerosing cholangitis. Consensus of the German Society of Digestive System and Metabolic Diseases].
    Beuers U; Wiedmann KH; Kleber G; Fleig WE
    Z Gastroenterol; 1997 Dec; 35(12):1041-9. PubMed ID: 9487636
    [No Abstract]   [Full Text] [Related]  

  • 32. Systematic review: recurrent autoimmune liver diseases after liver transplantation.
    Montano-Loza AJ; Bhanji RA; Wasilenko S; Mason AL
    Aliment Pharmacol Ther; 2017 Feb; 45(4):485-500. PubMed ID: 27957759
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diagnosis and management of overlap syndromes.
    Bunchorntavakul C; Reddy KR
    Clin Liver Dis; 2015 Feb; 19(1):81-97. PubMed ID: 25454298
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Autoimmune hepatitis and overlap syndrome: diagnosis].
    Berg PA; Klein R
    Praxis (Bern 1994); 2002 Aug; 91(34):1339-46. PubMed ID: 12233264
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Urinary tract infection as a risk factor for autoimmune liver disease: from bench to bedside.
    Smyk DS; Bogdanos DP; Kriese S; Billinis C; Burroughs AK; Rigopoulou EI
    Clin Res Hepatol Gastroenterol; 2012 Apr; 36(2):110-21. PubMed ID: 21907008
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Cholestatic liver diseases].
    Grimm D; Thimme R
    Ther Umsch; 2011 Apr; 68(4):195-9. PubMed ID: 21452140
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Steroid withdrawal under tacrolimus for primary biliary cirrhosis, primary sclerosing cholangitis and autoimmune hepatitis after liver transplantation and long-term survival.
    Jain A; Pokharna R; Eghtesad B; Potdar S; Kashyap R; Kingery L; Fung J
    Transplant Proc; 2002 Aug; 34(5):1524-5. PubMed ID: 12176467
    [No Abstract]   [Full Text] [Related]  

  • 38. Increased Posttransplant Mortality for Autoimmune Hepatitis Compared With Other Autoimmune Liver Diseases.
    Lee JY; Danford CJ; Patwardhan VR; Bonder A
    J Clin Gastroenterol; 2020 Aug; 54(7):648-654. PubMed ID: 31651572
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The impact of disease recurrence on graft survival following liver transplantation: a single centre experience.
    Rowe IA; Webb K; Gunson BK; Mehta N; Haque S; Neuberger J
    Transpl Int; 2008 May; 21(5):459-65. PubMed ID: 18225996
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Transplantation in autoimmune liver diseases.
    Mottershead M; Neuberger J
    World J Gastroenterol; 2008 Jun; 14(21):3388-95. PubMed ID: 18528936
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 30.